John Binns Discusses "Overview Of Anti-bribery And Criminal Law In The Life Sciences Sector" With LexisNexis

• Published date: 30 May 2022
• Subject Matter: Food, Drugs, Healthcare, Life Sciences, Criminal Law, Biotechnology & Nanotechnology, White Collar Crime, Anti-Corruption & Fraud
• Law Firm: BCL Solicitors LLP
• Author: Mr John Binns

BCL partner John Binns has produced a practice note for LexisNexis discussing anti-bribery and criminal law in the life sciences sector.

*Here is a short extract from the article:

There are various ways in which criminal law can interact with the life sciences sector. As well as offences against the person and controlled drugs offences, various 'corporate' or 'white collar' offences can be relevant for individuals and corporates, including counterfeiting, criminal cartel offences, money laundering and fraud, as well as bribery. Breaches of the sector's regulatory regime (including on medical devices, and inducements and hospitality) can also result in criminal liability. Enforcement through criminal investigations and proceedings may (but will not necessarily) follow.

Mental element and inchoate offences

For most UK criminal offences, guilt is determined by reference to an individual's state of mind (the 'mental element' of the offence). As well as direct involvement, individuals can be liable for...